171 related articles for article (PubMed ID: 33554259)
1. The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke.
Zhang J; Lenarczyk R; Marin F; Malaczynska-Rajpold K; Kosiuk J; Doehner W; Van Gelder IC; Lee G; Hendriks JM; Lip GYH; Potpara TS
Europace; 2021 Feb; 23(2):314-322. PubMed ID: 33554259
[TBL] [Abstract][Full Text] [Related]
2. Perceptions and knowledge gaps on CHA
Zhang C; Shen L; Pan MM; Zheng YL; Gu ZC; Lin HW
Postgrad Med; 2022 Jan; 134(1):64-77. PubMed ID: 34694951
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
[TBL] [Abstract][Full Text] [Related]
4. Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based survey.
Potpara TS; Ferro C; Lip GYH; Dan GA; Lenarczyk R; Mallamaci F; Ortiz A; Sarafidis P; Ekart R; Dagres N
Europace; 2020 Mar; 22(3):496-505. PubMed ID: 31965154
[TBL] [Abstract][Full Text] [Related]
5. Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.
Sulzgruber P; Wassmann S; Semb AG; Doehner W; Widimsky P; Gremmel T; Kaski JC; Savarese G; Rosano GMC; Borghi C; Kjeldsen K; Torp-Pedersen C; Schmidt TA; Lewis BS; Drexel H; Tamargo J; Atar D; Agewall S; Niessner A
Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):171-180. PubMed ID: 31119266
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
[TBL] [Abstract][Full Text] [Related]
7. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
8. Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey.
Iliodromitis K; Lenarczyk R; Scherr D; Conte G; Farkowski MM; Marin F; Garcia-Seara J; Simovic S; Potpara T
Europace; 2023 Feb; 25(2):667-675. PubMed ID: 36512365
[TBL] [Abstract][Full Text] [Related]
9. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?
Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Heart Rhythm; 2016 Jan; 13(1):46-53. PubMed ID: 26277496
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic therapy for stroke prevention in patients with atrial fibrillation who survive an intracerebral haemorrhage: results of an EHRA survey.
Ivany E; Lane DA; Dan GA; Doehner W; Farkowski MM; Iliodromitis K; Lenarczyk R; Potpara TS
Europace; 2021 May; 23(5):806-814. PubMed ID: 34020460
[TBL] [Abstract][Full Text] [Related]
12. Value of left atrial diameter with CHA2DS2-VASc score in predicting left atrial/left atrial appendage thrombosis in non-valvular atrial fibrillation.
Zhang Y; Yuan YQ
Arq Bras Cardiol; 2021 Feb; 116(2):325-331. PubMed ID: 33470330
[TBL] [Abstract][Full Text] [Related]
13. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Dong Y; Liu C
Cardiovasc Drugs Ther; 2020 Dec; 34(6):763-772. PubMed ID: 32583288
[TBL] [Abstract][Full Text] [Related]
14. Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS).
Richter D; Guasti L; Walker D; Lambrinou E; Lionis C; Abreu A; Savelieva I; Fumagalli S; Bo M; Rocca B; Jensen MT; Pierard L; Sudano I; Aboyans V; Asteggiano R
Eur J Prev Cardiol; 2022 Feb; 29(1):216-227. PubMed ID: 34270717
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
Dupree L; DeLosSantos M; Smotherman C
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
[TBL] [Abstract][Full Text] [Related]
16. Knowledge gaps, lack of confidence, and system barriers to guideline implementation among European physicians managing patients with CIED lead or infection complications: a European Heart Rhythm Association/European Society of Cardiology educational needs assessment survey.
Rao A; Garner D; Starck C; Kirkfeldt RE; Dagres N; Didier K; Montano N; Heidbuchel H
Europace; 2020 Nov; 22(11):1743-1753. PubMed ID: 33175984
[TBL] [Abstract][Full Text] [Related]
17. Association of the CHA2DS2-VASc score with left atrial spontaneous echo contrast: a cross-sectional study of patients with rheumatic mitral stenosis in sinus rhythm.
Belen E; Ozal E; Pusuroglu H
Heart Vessels; 2016 Sep; 31(9):1537-43. PubMed ID: 26475711
[TBL] [Abstract][Full Text] [Related]
18. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).
Lip GYH; Collet JP; Haude M; Byrne R; Chung EH; Fauchier L; Halvorsen S; Lau D; Lopez-Cabanillas N; Lettino M; Marin F; Obel I; Rubboli A; Storey RF; Valgimigli M; Huber K;
Europace; 2019 Feb; 21(2):192-193. PubMed ID: 30052888
[TBL] [Abstract][Full Text] [Related]
19. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
[TBL] [Abstract][Full Text] [Related]
20. Value of Combining Left Atrial Diameter and Amino-terminal Pro-brain Natriuretic Peptide to the CHA2DS2-VASc Score for Predicting Stroke and Death in Patients with Sick Sinus Syndrome after Pacemaker Implantation.
Mo BF; Lu QF; Lu SB; Xie YQ; Feng XF; Li YG
Chin Med J (Engl); 2017 Aug; 130(16):1902-1908. PubMed ID: 28776540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
